Su-Ying Liang, Ph.D.
795 El Camino Real, Ames Building
Palo Alto, CA 94301-2302
Su-Ying Liang, Ph.D., is a research economist at the Palo Alto Medical Foundation Research Institute (PAMFRI). She also holds appointments as a research health economist (since 2009) and adjunct professor at the University of California, San Francisco (since 2011). Previously, she was an assistant professor at Arizona State University.
Dr. Liang’s research applies economics and quantitative methods to examine policy issues in health care delivery and organization. Her research interests are medical care utilization and its impact on clinical care, with an emphasis on personalized medicine, genetic testing, and cancer screening procedures), physician compensation arrangements, and women’s health.
Her work has been published in peer-reviewed journals such as American Journal of Managed Care, Cancer, Contraception, Health Services and Outcomes Research Methodology, Health Services Research, JAMA, Medical Care, Medical Care Research and Review, and Nature Biotechnology. Dr. Liang serves as an ad hoc reviewer for ten journals. She is a former member of the scientific review committee for the International Health Economics Association (2009 and 2011).
Prior to joining PAMFRI, Dr. Liang served on the leadership team for the UCSF Center for Translational and Policy Research on Personalized Medicine (TRANSPERS). In this capacity, she provided expertise in economics, with particular skill in working with secondary data. Dr. Liang earned her doctorate in economics from the University of Washington. She holds a bachelor’s degree in economics from National Taiwan University.
In the News
- Out-of-Pocket Expenses for OCs Targeted, Pharmacy Choice, August 1, 2011
- Liang, et al., Contraception, October 2010Summary of "Women's Out-of-Pocket Expenditures and Dispensing Patterns for Oral Contraceptive Pills Between 1996 and 2006,", Women’s Health Policy Report, December 2, 2010
- Liang SY, Grossman D, Phillips KA. User characteristics and out-of-pocket expenditures for progestin-only versus combined oral contraceptives. Contraception. 2012 Dec;86(6):666-72. PMID: 22770791
- Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M. Genomic testing and therapies for breast cancer in clinical practice. J Oncol Pract. 2011 May;7(3 Suppl):e1s-7s. PMID: 21886507
- Van Bebber SL, Trosman JR, Liang SY, Wang G, Marshall DA, Knight S, Phillips KA. Capacity building for assessing new technologies: approaches to examining personalized medicine in practice. Per Med. 2010 Jul;7(4):427-439. PMID: 21857867
- Haas JS, Phillips KA, Liang SY, Hassett MJ, Keohane C, Elkin EB, Armstrong J, Toscano M.
Genomic testing and therapies for breast cancer in clinical practice. Am J Manag Care. 2011 May 1;17(5 Spec No):e174-81. PMID: 21711068
- Haas JS, Liang SY, Hassett MJ, Shiboski S, Elkin EB, Phillips KA. Gene expression profile testing for breast cancer and the use of chemotherapy, serious adverse effects, and costs of care. Breast Cancer Res Treat. 2011 Nov;130(2):619-26. PMID: 21681446
- Liang SY, Grossman D, Phillips KA. Women's out-of-pocket expenditures and dispensing patterns for oral contraceptive pills between 1996 and 2006. Contraception. 2011 Jun;83(6):528-36. PMID: 21570550
- Liang SY, Phillips KA, Wang G, Keohane C, Armstrong J, Morris WM, Haas JS. Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer. Med Care. 2011 Jun;49(6):e1-8. PMID: 21422962